CSL Shares Fall 11% After First-Half Net Profit Misses Estimate
CSL Ltd. shares dropped after the Australian biotech posted an 81% drop in first-half profit, as a new interim chief executive officer takes charge amid asset write-downs, weaker vaccine markets...
By Jason Gale, Amber Tong · Bloomberg Markets
CSL Ltd. shares dropped after the Australian biotech posted an 81% drop in first-half profit, as a new interim chief executive officer takes charge amid asset write-downs, weaker vaccine markets and a years-long slide in investor confidence.